One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-148039
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 17 |
Affiliation: Moffitt Cancer Center, Utrecht University, University of Kansas Cancer Center, The University of Texas MD Anderson Cancer Center, Institut d'Investigació Biomédica de Bellvitge, University of Barcelona, Institut Català d'Oncologia, University of Rochester, University Medical Center Groningen, Peter MacCallum Cancer Centre, University of Melbourne, Royal Melbourne Hospital, University of Chicago Medical Center, Hackensack University Medical Center, Tennessee Oncology, Sarah Cannon, Amsterdam University Medical Centers, University of Amsterdam, Swedish Medical Center, Washington University in St. Louis, Vancouver General Hospital, University of British Columbia, University of Maryland, Baltimore, Stanford University, Northwestern University, University Hospitals Birmingham NHS Foundation Trust, University of Iowa, Vanderbilt University, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute
Primary Analysis of ZUMA-7: A Phase 3 Randomized Trial of Axicabtagene Ciloleucel (Axi-Cel) Versus Standard-of-Care Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
